{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:03:14Z","timestamp":1768507394438,"version":"3.49.0"},"posted":{"date-parts":[[2023,8,14]]},"group-title":"Microbiology","reference-count":45,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,8,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  People with muco-obstructive pulmonary diseases such as cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) often have acute or chronic respiratory infections that are difficult to treat due in part to the accumulation of hyperconcentrated mucus within the airway. Mucus accumulation and obstruction promote chronic inflammation and infection and reduce therapeutic efficacy. Bacterial aggregates in the form of biofilms exhibit increased resistance to mechanical stressors from the immune response (e.g., phagocytosis) and chemical treatments including antibiotics. Herein, combination treatments designed to disrupt the mechanical properties of biofilms and potentiate antibiotic efficacy are investigated against mucus-grown\n                  <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                  biofilms and optimized to 1) alter biofilm viscoelastic properties, 2) increase mucociliary transport rates, and 3) reduce bacterial viability. A disulfide bond reducing agent (tris(2-carboxyethyl)phosphine, TCEP), a surfactant (NP40), a biopolymer (hyaluronic acid, HA), a DNA degradation enzyme (DNase), and an antibiotic (tobramycin) are tested in various combinations to maximize biofilm disruption. The viscoelastic properties of biofilms are quantified with particle tracking microrheology and transport rates are quantified in a mucociliary transport device comprised of fully differentiated primary human bronchial epithelial cells. The combination of the NP40 with hyaluronic acid and tobramycin was the most effective at increasing mucociliary transport rates, decreasing the viscoelastic properties of mucus, and reducing bacterial viability. Multimechanistic targeting of biofilm infections may ultimately result in improved clinical outcomes, and the results of this study may be translated into future in vivo infection models.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Author Summary<\/jats:title>\n                  <jats:p>One of the major challenges associated with chronic respiratory infections in cystic fibrosis and chronic obstructive pulmonary disease is difficult to treat biofilms that form in hyperconcentrated mucus. Biofilms are mechanically robust due to an exterior polymeric matrix that protects from the immune response and antibiotics. Antibiotics like tobramycin alone have little impact on the biofilm matrix, but disruption of viscous mucus and the biofilm architecture has previously been shown to improve antibiotic efficacy. Combination treatments must be used to break up mucus and biofilms and simultaneously kill bacteria. The most promising combination in this study includes the surfactant NP40, the biopolymer hyaluronic acid, and the antibiotic tobramycin which together decreased biofilm viscosity, reduced bacterial load, and increased mucociliary transport rates. The results from this study may be translated to an infected animal study for eventual clinical trials.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2023.08.14.553173","type":"posted-content","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:05:15Z","timestamp":1692057915000},"source":"Crossref","is-referenced-by-count":0,"title":["Combination Treatment to Improve Mucociliary Transport of\n                  <i>Pseudomonas aeruginosa<\/i>\n                  Biofilms"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0856-8640","authenticated-orcid":false,"given":"Kaitlyn R.","family":"Rouillard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Esther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Kissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas M.","family":"Plott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean W.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Markovetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9270-777X","authenticated-orcid":false,"given":"David B.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"issue":"4","key":"2023081722301103000_2023.08.14.553173v1.1","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1152\/physrev.00004.2021","article-title":"Physiology and pathophysiology of human airway mucus","volume":"102","year":"2022","journal-title":"Physiol Rev"},{"key":"2023081722301103000_2023.08.14.553173v1.2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/COPD.S346294","article-title":"Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis","volume":"17","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2023081722301103000_2023.08.14.553173v1.3","doi-asserted-by":"crossref","unstructured":"Malhotra S , Hayes D , Wozniak DJ . Cystic fibrosis and Pseudomonas aeruginosa: the host-microbe interface. Clin Microbiol Rev. 2019;32(3). Available from: http:\/\/cmr.asm.org\/lookup\/doi\/10.1128\/CMR.00138-18","DOI":"10.1128\/CMR.00138-18"},{"key":"2023081722301103000_2023.08.14.553173v1.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01297-2018"},{"key":"2023081722301103000_2023.08.14.553173v1.5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087681"},{"key":"2023081722301103000_2023.08.14.553173v1.6","doi-asserted-by":"crossref","unstructured":"Carpenter J , Wang Y , Gupta R , Li Y , Haridass P , Subramani DB , et al. Assembly and organization of the N-terminal region of mucin MUC5AC: Indications for structural and functional distinction from MUC5B. Proceedings of the National Academy of Sciences. 2021;118(39). Available from: https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.2104490118","DOI":"10.1073\/pnas.2104490118"},{"key":"2023081722301103000_2023.08.14.553173v1.7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq5049"},{"key":"2023081722301103000_2023.08.14.553173v1.8","doi-asserted-by":"publisher","DOI":"10.1042\/bj3610537"},{"issue":"8","key":"2023081722301103000_2023.08.14.553173v1.9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.bpj.2021.01.041","article-title":"Induction of ciliary orientation by matrix patterning and characterization of mucociliary transport","volume":"120","year":"2021","journal-title":"Biophys J"},{"issue":"2","key":"2023081722301103000_2023.08.14.553173v1.10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.chest.2018.03.005","article-title":"Cystic Fibrosis Sputum Rheology Correlates With Both Acute and Longitudinal Changes in Lung Function","volume":"154","year":"2018","journal-title":"Chest"},{"key":"2023081722301103000_2023.08.14.553173v1.11","doi-asserted-by":"crossref","first-page":"100080","DOI":"10.1016\/j.bioflm.2022.100080","article-title":"Prevalence of biofilms in acute infections challenges a longstanding paradigm","volume":"4","year":"2022","journal-title":"Biofilm"},{"key":"2023081722301103000_2023.08.14.553173v1.12","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217576"},{"issue":"4","key":"2023081722301103000_2023.08.14.553173v1.13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jpeds.2014.02.010","article-title":"Impaired mucociliary clearance in cystic fibrosis and P aeruginosa","volume":"164","year":"2014","journal-title":"J Pediatr"},{"key":"2023081722301103000_2023.08.14.553173v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2020.03.016"},{"key":"2023081722301103000_2023.08.14.553173v1.15","doi-asserted-by":"crossref","unstructured":"Dar D , Dar N , Cai L , Newman DK . Spatial transcriptomics of planktonic and sessile bacterial populations at single-cell resolution. Science (1979). 2021;373(6556). Available from: https:\/\/www.science.org\/doi\/10.1126\/science.abi4882","DOI":"10.1126\/science.abi4882"},{"key":"2023081722301103000_2023.08.14.553173v1.16","doi-asserted-by":"publisher","DOI":"10.1039\/c0sm01467b"},{"issue":"1","key":"2023081722301103000_2023.08.14.553173v1.17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41522-016-0007-9","article-title":"Evolutionary adaptations of biofilms infecting cystic fibrosis lungs promote mechanical toughness by adjusting polysaccharide production","volume":"3","year":"2017","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2023081722301103000_2023.08.14.553173v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.01.008"},{"issue":"6","key":"2023081722301103000_2023.08.14.553173v1.19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00430-020-00691-1","article-title":"Bacterial aggregate size determines phagocytosis efficiency of polymorphonuclear leukocytes","volume":"209","year":"2020","journal-title":"Med Microbiol Immunol"},{"key":"2023081722301103000_2023.08.14.553173v1.20","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuu008"},{"issue":"7","key":"2023081722301103000_2023.08.14.553173v1.21","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1021\/acsinfecdis.0c00246","article-title":"Pseudomonas aeruginosa Biofilm Eradication via Nitric Oxide-Releasing Cyclodextrins","volume":"6","year":"2020","journal-title":"ACS Infect Dis"},{"key":"2023081722301103000_2023.08.14.553173v1.22","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02397-18"},{"key":"2023081722301103000_2023.08.14.553173v1.23","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2011.0942"},{"key":"2023081722301103000_2023.08.14.553173v1.24","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky241"},{"key":"2023081722301103000_2023.08.14.553173v1.25","doi-asserted-by":"crossref","unstructured":"Rouillard KR , Markovetz MR , Kissner WJ , Boone WL , Plott LM , Hill DB . Altering the viscoelastic properties of mucus-grown Pseudomonas aeruginosa biofilms affects antibiotic susceptibility. Biofilm. 2023;100104. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590207523000011","DOI":"10.1016\/j.bioflm.2023.100104"},{"key":"2023081722301103000_2023.08.14.553173v1.26","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00471-08"},{"key":"2023081722301103000_2023.08.14.553173v1.27","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01721-15"},{"issue":"5","key":"2023081722301103000_2023.08.14.553173v1.28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jcf.2022.01.003","article-title":"Evaluating the alginate oligosaccharide (OligoG) as a therapy for Burkholderia cepacia complex cystic fibrosis lung infection","volume":"21","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2023081722301103000_2023.08.14.553173v1.29","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00525-12"},{"issue":"1","key":"2023081722301103000_2023.08.14.553173v1.30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41522-018-0056-3","article-title":"Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides","volume":"4","year":"2018","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2023081722301103000_2023.08.14.553173v1.31","doi-asserted-by":"publisher","DOI":"10.1080\/08927014.2013.777954"},{"issue":"4","key":"2023081722301103000_2023.08.14.553173v1.32","doi-asserted-by":"crossref","first-page":"e0029122","DOI":"10.1128\/msphere.00291-22","article-title":"Effects of Mucin and DNA Concentrations in Airway Mucus on Pseudomonas aeruginosa Biofilm Recalcitrance","volume":"7","year":"2022","journal-title":"mSphere"},{"key":"2023081722301103000_2023.08.14.553173v1.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2011.08.032"},{"key":"2023081722301103000_2023.08.14.553173v1.34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2500\/ajra.2011.25.3583","article-title":"The effect of dilute baby shampoo on nasal mucociliary clearance in healthy subjects","volume":"25","year":"2011","journal-title":"Am J Rhinol Allergy"},{"key":"2023081722301103000_2023.08.14.553173v1.35","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201802-0245OC"},{"key":"2023081722301103000_2023.08.14.553173v1.36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2015.04.028","article-title":"Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections","volume":"209","year":"2015","journal-title":"Journal of Controlled Release"},{"key":"2023081722301103000_2023.08.14.553173v1.37","doi-asserted-by":"publisher","DOI":"10.1021\/acs.langmuir.9b02188"},{"issue":"6","key":"2023081722301103000_2023.08.14.553173v1.38","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1021\/acsbiomaterials.2c00392","article-title":"Role of Nitric Oxide-Releasing Glycosaminoglycans in Wound Healing","volume":"8","year":"2022","journal-title":"ACS Biomater Sci Eng"},{"key":"2023081722301103000_2023.08.14.553173v1.39","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00238.2019"},{"issue":"3","key":"2023081722301103000_2023.08.14.553173v1.40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/1040841X.2021.1962802","article-title":"Water in bacterial biofilms: pores and channels, storage and transport functions","volume":"48","year":"2022","journal-title":"Crit Rev Microbiol"},{"key":"2023081722301103000_2023.08.14.553173v1.41","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.7b00809"},{"key":"2023081722301103000_2023.08.14.553173v1.42","doi-asserted-by":"publisher","DOI":"10.1136\/thx.40.2.125"},{"key":"2023081722301103000_2023.08.14.553173v1.43","doi-asserted-by":"publisher","DOI":"10.1086\/656788"},{"issue":"1","key":"2023081722301103000_2023.08.14.553173v1.44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/acsinfecdis.0c00337","article-title":"Exogenous Nitric Oxide Improves Antibiotic Susceptibility in Resistant Bacteria","volume":"7","year":"2021","journal-title":"ACS Infect Dis"},{"key":"2023081722301103000_2023.08.14.553173v1.45","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-013-1876-y"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.08.14.553173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:04:31Z","timestamp":1768453471000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2023.08.14.553173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":45,"URL":"https:\/\/doi.org\/10.1101\/2023.08.14.553173","relation":{},"subject":[],"published":{"date-parts":[[2023,8,14]]},"subtype":"preprint"}}